KP Tissue Inc. (TSX:KPT)
Canada · Delayed Price · Currency is CAD 12.94
+0.02 (0.15%)
Jul 31, 2026, 3:55 PM EST
KP Tissue Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Receivables | 1.8 | 0.08 | 1.8 | 1.79 | 1.79 | 1.78 |
Total Trade Receivables | 1.8 | 0.08 | 1.8 | 1.79 | 1.79 | 1.78 |
Other Current Assets | - | 2.96 | - | 0.65 | 0.58 | 0.21 |
Total Current Assets | 1.8 | 678.08 | 1.8 | 2.45 | 2.37 | 1.99 |
Long-Term Investments | 71.08 | - | 69.52 | 68.16 | 79.34 | 78.73 |
Total Assets | 72.88 | 2,609 | 71.32 | 70.61 | 81.71 | 80.72 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 13.44 | - | 0.46 | 0.17 | 0.25 |
Short-Term Debt | - | - | - | - | - | 2.01 |
Other Current Liabilities | 1.8 | - | 1.8 | 1.79 | 1.79 | 1.78 |
Total Current Liabilities | 1.8 | 534.43 | 1.8 | 2.25 | 1.96 | 4.04 |
Other Long-Term Liabilities | - | 75.2 | - | - | 5.72 | 0.81 |
Total Long-Term Liabilities | - | 75.2 | - | - | 5.72 | 0.81 |
Total Liabilities | 1.8 | 1,902 | 1.8 | 2.25 | 7.68 | 4.85 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 23.07 | - | 22.76 | 22.56 | 22.38 | 21.84 |
Additional Paid-in Capital | 144.82 | 395.38 | 144.82 | 144.82 | 144.82 | 144.82 |
Accumulated Other Comprehensive Income | 17.38 | 89.34 | 18.61 | 16.01 | 14.84 | 12.77 |
Retained Earnings | -114.19 | -151.97 | -116.67 | -115.03 | -108.01 | -103.56 |
Shareholders' Equity | 71.08 | 706.55 | 69.52 | 68.36 | 74.03 | 75.87 |
Total Liabilities & Equity | 72.88 | 2,609 | 71.32 | 70.61 | 81.71 | 80.72 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 0 | 0 | 0 | 0 | 2.01 |
Net Cash (Debt) | - | -0 | -0 | -0 | -0 | -2.01 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | - | - | - | - | - | -0.20 |
Book Value | 71.08 | 706.55 | 69.52 | 68.36 | 74.03 | 75.87 |
Book Value Per Share | 7.10 | 70.63 | 6.97 | 6.87 | 7.45 | 7.71 |
Tangible Book Value | 71.08 | 706.55 | 69.52 | 68.36 | 74.03 | 75.87 |
Tangible Book Value Per Share | 7.10 | 70.63 | 6.97 | 6.87 | 7.45 | 7.71 |